Wed, November 6, 2019
Tue, November 5, 2019
Mon, November 4, 2019
Fri, November 1, 2019
Thu, October 31, 2019
Wed, October 30, 2019
Tue, October 29, 2019
Mon, October 28, 2019
Fri, October 25, 2019
Thu, October 24, 2019

Paul Matteis Maintained (VRTX) at Strong Buy with Increased Target to $229 on, Oct 31st, 2019

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-increased-target-to-229-on-oct-31st-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

- Click to Lock Slider
Paul Matteis of Stifel, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Increased Target from $211 to $229 on, Oct 31st, 2019.

Paul has made no other calls on VRTX in the last 4 months.



There are 4 other peers that have a rating on VRTX. Out of the 4 peers that are also analyzing VRTX, 1 agrees with Paul's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Alan Carr of "Needham" Downgraded from Strong Buy to Hold on, Thursday, August 1st, 2019


These are the ratings of the 3 analyists that currently disagree with Paul


  • Robyn Karnauskas of "Citigroup" Maintained at Strong Buy with Increased Target to $225 on, Tuesday, October 22nd, 2019
  • Ying Huang of "B of A Securities" Initiated at Strong Buy and Held Target at $220 on, Thursday, October 17th, 2019
  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $213 on, Thursday, August 1st, 2019